AG真人官方

STOCK TITAN

[SCHEDULE 13G] Eledon Pharmaceuticals, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:07/29/2025
Eledon Pharmaceuticals Inc

NASDAQ:ELDN

ELDN Rankings

ELDN Latest News

ELDN Latest SEC Filings

ELDN Stock Data

205.99M
59.03M
1.4%
68.99%
5.19%
Biotechnology
Pharmaceutical Preparations
United States
IRVINE